Navigation Links
Mainz University Medical Center receives further DFG funding for cardiovascular research
Date:1/29/2013

The German Research Foundation (DFG) has again approved funding for the Department of Internal Medicine II of the Mainz University Medical Center to promote cardiovascular research for the second time within only a few weeks. The aim of the project currently being sponsored is to investigate the relationships between free radicals and disorders of the cardiovascular system. The team, led by biologist Dr. Swenja Krller-Schn and PD Dr. Eberhard Schulz, senior physician at the Department of Internal Medicine II of the Mainz University Medical Center, has a particular interest in how specific enzyme systems regulate vascular function. These significantly influence the formation of free radicals, inflammatory reactions, and vascularization. It is thus hoped that the results of this theoretical research will make it possible to diagnose vascular diseases at an even earlier stage and to intervene with targeted treatment to prevent related complications, such as myocardial infarction. The researchers intend to spend the approximately EUR 210,000 funding granted over the next two years on human resources and consumables.

In this project, the research team will be studying to what extent molecules that control the energy consumption of cells also have a long-term effect on vascular function. "This correlation seems to make sense because when energy reserves decrease, cells need to be supplied with substrates in the blood stream and, for this purpose, adequate dilation of the blood vessels is necessary. However, the correlations between the mechanisms involved in this process have still not been sufficiently explained," stated Krller-Schn and Schulz.

The successful acquisition of third-party funds is also attributable to the strategy adopted by the University Medical Center, namely that of establishing specialized research units. Within this context, the research team led by Dr. Swenja Krller-Schn and PD Dr. Eberhard Schulz has managed to form partnerships that are important for the future of translational medicine. "We are pleased that the German Research Foundation has recognized our achievements and has decided to sponsor us. The work of the Research Unit Vascular Prevention and the establishment of the Center for Thrombosis and Hemostasis (CTH) with the support of the Mainz Heart Foundation have created an environment in which applications have a greater chance of success," said Prof. Dr. Thomas Mnzel, Coordinator of the Research Unit Vascular Prevention at Mainz University Medical Center.


'/>"/>

Contact: Swenja Krller-Schn
swenja.kroeller-schoen@gmx.de
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related medicine news :

1. DFG funds new Collaborative Research Center at the Mainz University Medical Center
2. Scientists at Mainz University identify inhibitor of myelin formation in the central nervous system
3. Scientists at the Mainz University Medical Center gain new insights into Taspase1 function
4. University of Tennessee researcher finds first time could predict sexual satisfaction
5. Lavender Languages Conference celebrates 20 years at American University
6. Spring Classes for Wexford University’s Online Doctoral Degree in Applied Sport Psychology Begin April 1
7. To Meet Growing Demand for Sports Psychology Experts, Wexford University Offers Master’s Degree in Applied Sport Psychology: Classes Begin April 1
8. Wexford University’s Master’s Degree in Nutrition and Exercises Prepares Weight Management Coaches and Consultants: Spring Quarter Launches April 1
9. Wayne State University researcher to evaluate success of text message diabetes intervention
10. University of Southern Mississippi Department of Marine Science Researches Marine Algae as Alternative Fuel Source
11. McGill University Launches a Major New Study on HPV Prevention Using Divine 9 Personal Lubricants with Carragel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
(Date:6/20/2017)... ... , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. Kejriwal ... leading-edge care, whether or not they have a referral. Dr. Kejriwal offers state-of-the-art ... laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. This ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... (AHN) Jefferson Hospital is providing physicians with advanced capabilities for diagnosing and treating ... than traditional MRIs, enabling doctors to get a more accurate look inside the ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: